172 related articles for article (PubMed ID: 19760033)
1. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer.
McIntyre E; Blackburn E; Brown PJ; Johnson CG; Gullick WJ
Breast Cancer Res Treat; 2010 Jul; 122(1):105-10. PubMed ID: 19760033
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
3. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
4. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
Thøgersen VB; Sørensen BS; Poulsen SS; Orntoft TF; Wolf H; Nexo E
Cancer Res; 2001 Aug; 61(16):6227-33. PubMed ID: 11507076
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of ErbB receptors and ligands in human meningiomas.
Laurendeau I; Ferrer M; Garrido D; D'Haene N; Ciavarelli P; Basso A; Vidaud M; Bieche I; Salmon I; Szijan I
Cancer Invest; 2009 Jul; 27(6):691-8. PubMed ID: 19440932
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
deFazio A; Chiew YE; Sini RL; Janes PW; Sutherland RL
Int J Cancer; 2000 Aug; 87(4):487-98. PubMed ID: 10918187
[TBL] [Abstract][Full Text] [Related]
7. Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study.
Shirai H; Ueno E; Osaki M; Tatebe S; Ito H; Kaibara N
Anticancer Res; 1995; 15(6B):2889-94. PubMed ID: 8669884
[TBL] [Abstract][Full Text] [Related]
8. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
Riese DJ; Bermingham Y; van Raaij TM; Buckley S; Plowman GD; Stern DF
Oncogene; 1996 Jan; 12(2):345-53. PubMed ID: 8570211
[TBL] [Abstract][Full Text] [Related]
9. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
[TBL] [Abstract][Full Text] [Related]
10. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.
Sundaresan S; Roberts PE; King KL; Sliwkowski MX; Mather JP
Endocrinology; 1998 Dec; 139(12):4756-64. PubMed ID: 9832411
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
Hudelist G; Singer CF; Manavi M; Pischinger K; Kubista E; Czerwenka K
Breast Cancer Res Treat; 2003 Aug; 80(3):353-61. PubMed ID: 14503808
[TBL] [Abstract][Full Text] [Related]
12. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G
J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926
[TBL] [Abstract][Full Text] [Related]
13. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.
Witton CJ; Reeves JR; Going JJ; Cooke TG; Bartlett JM
J Pathol; 2003 Jul; 200(3):290-7. PubMed ID: 12845624
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptors and epidermal growth factor, amphiregulin and neuregulin in bovine uteroplacental tissues during gestation.
Akbalik ME; Ketani MA
Placenta; 2013 Dec; 34(12):1232-42. PubMed ID: 24138732
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells.
O-Charoenrat P; Rhys-Evans P; Eccles S
Int J Cancer; 2000 Dec; 88(5):759-65. PubMed ID: 11072245
[TBL] [Abstract][Full Text] [Related]
16. The epidermal growth factor family has a dual role in deciding the fate of cancer cells.
Memon AA; Sorensen SB; Nexo E
Scand J Clin Lab Invest; 2006; 66(7):623-30. PubMed ID: 17101554
[TBL] [Abstract][Full Text] [Related]
17. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
18. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
[TBL] [Abstract][Full Text] [Related]
19. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer.
Srinivasan R; Benton E; McCormick F; Thomas H; Gullick WJ
Clin Cancer Res; 1999 Oct; 5(10):2877-83. PubMed ID: 10537356
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]